Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Bombay S.E.
03:32:30 01/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,464.20 INR | -1.03% |
|
+3.25% | +21.04% |
| Market Cap | 70TCr 734.31Cr 633.29Cr 595.71Cr 543.29Cr 1.02TCr 1.03TCr 7.06TCr 2.74TCr 35TCr 2.76TCr 2.7TCr 1,17600Cr | P/E 2027 * |
30x | P/E 2028 * | 25x |
|---|---|---|---|---|---|
| Enterprise Value | 66TCr 695.87Cr 600.14Cr 564.53Cr 514.85Cr 967.47Cr 973.88Cr 6.69TCr 2.6TCr 34TCr 2.61TCr 2.56TCr 1,11500Cr | EV / Sales 2027 * |
3.93x | EV / Sales 2028 * | 3.47x |
| Free-Float |
51.04% | Yield 2027 * |
0.15% | Yield 2028 * | 0.16% |
Last Transcript : Glenmark Pharmaceuticals Limited
| 1 day | -1.03% | ||
| 1 week | +3.25% | ||
| Current month | -1.03% | ||
| 1 month | +10.34% | ||
| 3 months | +8.35% | ||
| 6 months | +15.27% | ||
| Current year | +21.04% |
| 1 week | 2,385.75 |  | 2,536.85 |
| 1 month | 2,163 | | 2,536.85 |
| Current year | 1,842.8 | | 2,536.85 |
| 1 year | 1,794 | | 2,536.85 |
| 3 years | 702.05 | | 2,536.85 |
| 5 years | 348.9 | | 2,536.85 |
| 10 years | 168 | | 2,536.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.03% | +3.25% | - | - | 735.54Cr | |
| -2.81% | +0.99% | +20.98% | +73.53% | 5TCr | |
| +1.14% | +1.47% | +59.54% | +123.40% | 4.03TCr | |
| +0.56% | +5.80% | +19.04% | +86.59% | 1.22TCr | |
| +0.98% | -1.04% | -10.47% | +13.15% | 1.2TCr | |
| +0.57% | +2.72% | +31.59% | +153.11% | 924.83Cr | |
| -0.15% | -1.65% | +27.65% | +48.56% | 761.82Cr | |
| -0.39% | +3.33% | +28.41% | +222.15% | 735.54Cr | |
| +1.43% | +1.70% | +50.00% | -9.99% | 720.79Cr | |
| -0.13% | +0.79% | -36.70% | +15.26% | 525.95Cr | |
| Average | +0.02% | +1.16% | +21.11% | +80.64% | 1.68TCr | |
| Weighted average by Cap. | -0.46% | +1.81% | +29.33% | +87.93% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17TCr 176.88Cr 152.54Cr 143.49Cr 130.86Cr 245.91Cr 247.54Cr 1.7TCr 660.6Cr 8.54TCr 664.06Cr 649.65Cr 28TCr | 19TCr 197.1Cr 169.98Cr 159.9Cr 145.82Cr 274.02Cr 275.84Cr 1.89TCr 736.12Cr 9.52TCr 739.98Cr 723.92Cr 32TCr |
| Net income | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 234Cr 91Cr 1.18TCr 91Cr 89Cr 3.9TCr | 2.77TCr 29Cr 25Cr 24Cr 22Cr 41Cr 41Cr 280.54Cr 109Cr 1.41TCr 109.57Cr 107.19Cr 4.68TCr |
| Net Debt | -3.65TCr -38Cr -33Cr -31Cr -28Cr -53Cr -54Cr -369.48Cr -143.55Cr -1.86TCr -144.3Cr -141.17Cr -6.16TCr | -4.8TCr -51Cr -44Cr -41Cr -37Cr -70Cr -71Cr -486.04Cr -188.84Cr -2.44TCr -189.83Cr -185.71Cr -8.1TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | ₹2,464.20 | -1.03% | 17,692 |
| 31/26/31 | ₹2,489.85 | -1.09% | 38,805 |
| 28/26/28 | ₹2,517.40 | +2.50% | 19,900 |
| 27/26/27 | ₹2,456.00 | +0.66% | 17,019 |
| 26/26/26 | ₹2,440.00 | +1.88% | 12,072 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
